Minister of India's northern state Uttar Pradesh dies of Covid-19


NEW DELHI, Aug. 2 (Xinhua): Kamal Rani, a minister of India's northern state of Uttar Pradesh, died of Covid-19 on Sunday, a spokesman of the state government confirmed.

She was reportedly undergoing treatment at a hospital in state capital Lucknow.

Kamal is the first senior politician and a minister in any state government across the country to have died of Covid-19.

Aged 62, Kamal had tested positive for the novel Coronavirus on July 18.

She served as the Minister of Technical Education in the Uttar Pradesh government.

State Chief Minister Yogi Adityanath expressed his condolences on her demise, saying that the state had lost a committed political leader.

Indian President Ram Nath Kovind tweeted: "Saddened by the untimely demise of Kamal Rani, cabinet minister in the Uttar Pradesh Government. Well respected for serving people at the grassroots, she had also served as an MP in the Lok Sabha twice.

"My condolences to her family and followers."

Chief Minister of central state of Madhya Pradesh Shivraj Singh Chouhan in last week tested positive for Covid-19.

He is undergoing required treatment.

So far 37,364 people have died of Covid-19 in the country, and the total tally stands at 1,750,723. - Xinhua
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

91% readers found this article insightful

Next In Aseanplus News

How RCEP benefits Singaporeans and businesses
No decision yet on KL-Spore high-speed rail: Malaysia
S.Korea foils N. Korea attempt to hack Covid-19 vaccine makers
Indonesia signs coal shipment contract with Chinese traders
Pakistan shelling kills 3 Indian soldiers in Kashmir: India
China has over 700,000 5G base stations: official
Indian firm to make Russia’s Sputnik V Covid-19 vaccine
No year-end bonus for Singapore civil servants
Vietnam returns eight Cambodian women tricked into illegal China work
AstraZeneca likely to run new global trial on Covid-19 vaccine

Stories You'll Enjoy